BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4342032)

  • 1. In vitro stimulation of human lymphocytes by Epstein-Barr virus.
    Gerber P; Lucas SJ
    Cell Immunol; 1972 Oct; 5(2):318-24. PubMed ID: 4342032
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies of the Epstein-Barr virus-host relationship: autochthonous and allogeneic lymphocyte stimulation by lymphoblast cell lines in mixed cell culture.
    Bausher JC; Smith RT
    Clin Immunol Immunopathol; 1973 Jan; 1(2):270-81. PubMed ID: 4357798
    [No Abstract]   [Full Text] [Related]  

  • 3. Whole-blood culture technique for functional studies of lymphocyte reactivity to mitogens, antigens, and homologous lymphocytes.
    Pauly JL; Sokal JE; Han T
    J Lab Clin Med; 1973 Sep; 82(3):500-12. PubMed ID: 4580576
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on oncogenic properties of Epstein-Barr virus.
    Gerber P; Deal DR
    Bibl Haematol; 1973; 39():428-38. PubMed ID: 4360172
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro stimulation of lymphocytes of donors seronegative for Epstein-Barr virus by preparations of inactivated Epstein-Barr virus.
    Chang RS; Spina CA
    J Infect Dis; 1976 Jun; 133(6):676-80. PubMed ID: 180190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is Epstein-Barr virus a human tumor virus?
    Gerber P
    Natl Cancer Inst Monogr; 1973 May; 36():65-71. PubMed ID: 4355351
    [No Abstract]   [Full Text] [Related]  

  • 7. A seroepidemiological study of Epstein-Barr virus and other viral antigens in sarcoidosis.
    Byrne EB; Evans AS; Fouts DW; Israel HL
    Am J Epidemiol; 1973 May; 97(5):355-63. PubMed ID: 4349694
    [No Abstract]   [Full Text] [Related]  

  • 8. Early events in transformation of human cord leukobytes by Epstain-Barr virus: induction of DNA synthesis, mitosis and the virus-associated nuclear antigen synthesis.
    Aya T; Osato T
    Int J Cancer; 1974 Sep; 14(3):341-7. PubMed ID: 4376517
    [No Abstract]   [Full Text] [Related]  

  • 9. Epstein-Barr virus (EBV) receptors, complement receptors, and EBV infectibility of different lymphocyte fractions of human peripheral blood. II. Epstein-Barr virus studies.
    Einhorn L; Steinitz M; Yefenof E; Ernberg I; Bakacs T; Klein G
    Cell Immunol; 1978 Jan; 35(1):43-58. PubMed ID: 202404
    [No Abstract]   [Full Text] [Related]  

  • 10. Relationship between Epstein-Barr virus-determined complement-fixing antigen and nuclear antigen detected by anticomplement fluorescence.
    Klein G; Vonka V
    J Natl Cancer Inst; 1974 Dec; 53(6):1645-6. PubMed ID: 4373574
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization of Epstein-Barr virus (EBV) antigens II. Detection of early antigen (S) using anticomplement immunofluorescence (ACIF) et complement fixation (CF) tests.
    Lenoir G; Berthelon MC; Favre MC; De-Thé G
    Biomedicine; 1975 Dec; 23(10):461-4. PubMed ID: 177116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-dependent lymphocyte cytotoxicity against cells expressing Epstein-Barr virus antigens.
    Pearson GR; Orr TW
    J Natl Cancer Inst; 1976 Mar; 56(3):485-8. PubMed ID: 176393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged oropharyngeal excretion of Epstein-Barr virus after infectious mononucleosis.
    Miller G; Niederman JC; Andrews LL
    N Engl J Med; 1973 Feb; 288(5):229-32. PubMed ID: 4345064
    [No Abstract]   [Full Text] [Related]  

  • 14. Separation of the complement-fixing and early antigens from Epstein-Barr soluble antigen.
    Wainwright WH; Veltri RW
    J Natl Cancer Inst; 1977 Apr; 58(4):1111-3. PubMed ID: 66320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human lymphoid cell transformation by Epstein-Barr virus.
    Pope JH; Scott W; Moss DJ
    Nat New Biol; 1973 Dec; 246(153):140-1. PubMed ID: 4357390
    [No Abstract]   [Full Text] [Related]  

  • 16. Epstein-Barr virus infections.
    Middleton PJ
    Can Med Assoc J; 1974 Jan; 110(1):9-10. PubMed ID: 4358535
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of sera from patients with sarcoidosis on in vitro lymphocyte response.
    Belcher RW; Carney JF; Nankervis GA
    Int Arch Allergy Appl Immunol; 1974; 46(2):183-90. PubMed ID: 4817738
    [No Abstract]   [Full Text] [Related]  

  • 18. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes.
    Miller G; Lipman M
    Proc Natl Acad Sci U S A; 1973 Jan; 70(1):190-4. PubMed ID: 4346033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The macrophage aggregation assay for cell-mediated immunity in man. Studies of patients with Hodgkin's disease and sarcoidosis.
    Gotoff SP; Lolekha S; Lopata M; Kopp J; Kopp RL; Malecki TJ
    J Lab Clin Med; 1973 Oct; 82(4):682-91. PubMed ID: 4585463
    [No Abstract]   [Full Text] [Related]  

  • 20. Lymphocyte stimulation in Candida albicans infections.
    Frisk A; von Stedingk LV; Wasserman J
    Sabouraudia; 1974 Mar; 12(1):87-94. PubMed ID: 4210102
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.